heres the case for DXCM $DexCom (DXCM.US)$
Stock fell in June due to missed earnings, but likely competitors took opportunity to chum the press. Fundamentally Dexcom is a phenomenal company with the edge on the market as their products have patented tech  (most accurate on the market). They have major contracts with large insulin pump providers and cell carriers. They have a follow app for family members to track their loved one’s glucose (think children with diabetes). It’s a ...